83
Participants
Start Date
March 4, 2002
Primary Completion Date
March 31, 2003
Study Completion Date
March 31, 2003
HuMax-CD4
HuMax-CD4 80 mg was administered as a subcutaneous infusion BID with 2 weeks interval followed by administration every 4 weeks up to Week 22.
Placebo
Placebo was administered as a subcutaneous infusion twice (BID) with 2 weeks interval followed by administration every 4 weeks up to Week 22.
Humax-CD4
HuMax-CD4 160 mg was administered as a subcutaneous infusion BID with 2 weeks interval followed by administration every 4 weeks up to Week 22.
One Crouse Medical Plaza, Syracuse
East Pennsylvania Rheumatology, Bethlehem
Clinical Research Center of Reading, West Reading
Osteoporosis and Clinical Trials Center, Hagerstown
Lewis Gayle Clinic, Salem
C.A.R.E. Center, Raleigh
nTouch Research, Decatur
Arthritis Associates of South Florida, Delray Beach
Tampa Medical Group Research, Tampa
nTouch Research, St. Petersburg
Ocala Rheumatology Research Center, Ocala
Radiant Research, Inc., Stuart
University of Louisville Hospital, Louisville
DataPharm, Inc., Canfield
Disease Study Group / Deaconess Hospital, Cincinnati
West Pharmaceutical Services, Evansville
Fiechtner Research, Lansing
Midwest Arthritis Center, Kalamazoo
Arthritis Education and Treatment Center, Grand Rapids
Mercy Arthritis Center, Des Moines
Medical Arts Center, Milwaukee
Deerbrook Medical Associates, Vernon Hills
Advocate Medical Group, Park Ridge
North Western Center for Clinical Research, Chicago
Rheumatology Associates, P.C., Chicago
The Arthritis Center, Springfield
Westroads Medical Group, Omaha
Lynn Health Science, Oklahoma City
Presbyterian Hospital of Dallas, Dallas
Idaho Arthritis & Osteoporosis Center, Meridian Hills
IHC Clinical Research Foundation, Salt Lake City
Arthritis Center of Reno, Reno
West Coast Clinical Research, Van Nuys
Rheumatology & Internal Medicine, Boling Clinical Trials, Rancho Cucamonga
Radiant Research, Inc., San Diego
Advances in Medicine, Rancho Mirage
Providence Arthritis Center, Portland
Northwest Rheumatology Associates, PC, Portland
Rheumatology Clinic, Medford
Bend Memorial Clinic, Bend
Evergreen Medical & Dental Center, Kirkland
Minor & James Med., First Hill Medical Building, Seattle
South Puget Sound Clinical Research Center, Olympia
Internal Medicine Association of Yakima, Inc., P.S., Yakima
Rheumatology Associates, Montgomery
Pro Health Partners, Inc., Long Beach
Arthritis Center of CT, Waterbury
Beth Israel Deaconess Medical Center, Boston
Altoona Arthritis & Osteoporosis Center, Duncansville
Medical College of Virginia, Div. of Rheum., Richmond
CIADS, Medical Arts Building, Winnipeg
Ottawa Hospital-General Campus, Ottawa
Sunnybrook/Women's College Research Health Science Center, Toronto
Institute de Rhumtologie de Montreal, Montreal
Lead Sponsor
Genmab
INDUSTRY